title: Botulinum toxin type B blocks sudomotor function effectively: a 6 month follow up.
abstract: This study analyzes the suppression of sweat gland activity by botulinum toxin type B. We injected botulinum toxin type B (between 2 and 1000 mouse units subcutaneously) in the lateral side of both lower legs in 15 healthy volunteers. Sweat tests were carried out before botulinum toxin type B injections, and at 3 wk, 3 mo, and 6 mo. We studied focal anhidrosis by iodine-starch staining and by capacitance hygrometry after carbachol iontophoresis, according to the quantitative sudomotor axon reflex test (QSART). Iodine starch staining indicated that a threshold dose of 8 mouse units botulinum toxin type B leads to anhidrotic skin spots (>4 cm2) after 3 wk. Duration of anhidrosis was prolonged for 3 mo when 15 mouse units and for 6 mo when 125 mouse units botulinum toxin type B were injected. The size of the anhidrotic area decreased with time (p<0.001), indicating partial recovery at the edges. After 3 wk, the QSART score had significantly decreased to 18% of baseline and had decreased to zero in most subjects with doses of 62.5 mouse units or more. After 3 mo, the QSART had returned to 91% of baseline in all but one subject and, after 6 mo, recovery of sudomotor function was complete. Analysis by iodine-starch staining and QSART indicated that botulinum toxin type B suppresses sudomotor function effectively, in a concentration-dependent manner.
authors.affiliation: Neurologische Klinik, Johannes-Gutenberg Universität, Mainz, Germany. birklein@neurologie.klinik.uni-mainz.de
authors.forename: Frank
authors.initials: F
authors.lastname: Birklein
authors.forename: Gabi
authors.initials: G
authors.lastname: Eisenbarth
authors.forename: Frank
authors.initials: F
authors.lastname: Erbguth
authors.forename: Martin
authors.initials: M
authors.lastname: Winterholler
mesh_terms: D001905:Botulinum Toxins / Q000008:administration & dosage* / Q000009:adverse effects; D019274:Botulinum Toxins, Type A; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006945:Hyperhidrosis / Q000188:drug therapy; D007007:Hypohidrosis / Q000139:chemically induced; D007455:Iodine; D007866:Leg; D008297:Male; D013194:Staining and Labeling; D013213:Starch; D013545:Sweat Glands / Q000187:drug effects* / Q000294:innervation / Q000502:physiology; D013546:Sweating / Q000187:drug effects*
chemical_list: C096323:rimabotulinumtoxinB; D013213:Starch; D007455:Iodine; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A